Salicylic acid
{{DrugProjectFormSinglePage |authorTag=Ammu Susheela, M.D. [1] |genericName=Salicylic acid |aOrAn=a |drugClass=anti acne agent |indicationType=treatment |indication=acne, for relief of itching, irritation, redness and scaling assoicated with psoriasis, eczema and seborrheic dermatitis |adverseReactions=hypersensitivity reaction, salicylate toxicity |blackBoxWarningTitle=ConditionName: |blackBoxWarningBody=ConditionName:
- Content
|fdaLIADAdult=* FOR THE TREATMENT OF ACNE
- HELPS KEEP SKIN CLEAR OF NEW ACNE BLEMISHES
- For relief of itching, irritation, redness and scaling assoicated with psoriasis, eczema and seborrheic dermatitis.
|offLabelAdultGuideSupport=* Acne vulgaris
- Apply TOPICALLY in concentrations of 0.5% to 10%
Disorder of skin, Hyperkeratotic: gel, apply TOPICALLY to the affected area and occlude the area at night.
- Disorder of skin, Hyperkeratotic
- shampoo, wet hair and apply TOPICALLY to the scalp, work into a lather and rinse; repeat the treatment as needed until the condition clears.
- Psoriasis
- Apply TOPICALLY in concentrations of 3% to 6%
- Removal of wart
- Apply TOPICALLY once or twice daily in concentrations of 5% to 40% for up to 12 weeks
|offLabelAdultNoGuideSupport=
There is limited information regarding Off-Label Non–Guideline-Supported Use of Salicylic acid in adult patients.
|fdaLIADPed=
There is limited information regarding FDA-Labeled Use of Salicylic acid in pediatric patients.
|offLabelPedGuideSupport=
There is limited information regarding Off-Label Guideline-Supported Use of Salicylic acid in pediatric patients.
|offLabelPedNoGuideSupport= There is limited information regarding Off-Label Non–Guideline-Supported Use of Salicylic acid in pediatric patients.
|warnings=* For external use only.
- Avoid contact with eyes. If contact occurs, rinse thoroughly with water.
- Do not use without consulting a doctor if the condition appears over a large portion of hte body.
- If condition worsens, or does not improve after using as directed, consult physician.
- Do not use for prolonged periods without consulting a doctor.
|clinicalTrials=There is limited information regarding Clinical Trial Experience of Salicylic acid in the drug label. |postmarketing=There is limited information regarding Postmarketing Experience of Salicylic acid in the drug label. |useInPregnancyFDA=* Pregnancy Category |useInPregnancyAUS=* Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Salicylic acid in women who are pregnant. |useInLaborDelivery=There is no FDA guidance on use of Salicylic acid during labor and delivery. |useInNursing=There is no FDA guidance on the use of Salicylic acid with respect to nursing mothers. |useInPed=There is no FDA guidance on the use of Salicylic acid with respect to pediatric patients. |useInGeri=There is no FDA guidance on the use of Salicylic acid with respect to geriatric patients. |useInGender=There is no FDA guidance on the use of Salicylic acid with respect to specific gender populations. |useInRace=There is no FDA guidance on the use of Salicylic acid with respect to specific racial populations. |useInRenalImpair=There is no FDA guidance on the use of Salicylic acid in patients with renal impairment. |useInHepaticImpair=There is no FDA guidance on the use of Salicylic acid in patients with hepatic impairment. |useInReproPotential=There is no FDA guidance on the use of Salicylic acid in women of reproductive potentials and males. |useInImmunocomp=There is no FDA guidance one the use of Salicylic acid in patients who are immunocompromised.
|administration=* Oral
|monitoring=There is limited information regarding Monitoring of Salicylic acid in the drug label.
|IVCompat=There is limited information regarding IV Compatibility of Salicylic acid in the drug label.
|overdose=There is limited information regarding Chronic Overdose of Salicylic acid in the drug label.
|drugBox=
| Template:Chembox header2 | Salicylic acid | |
|---|---|
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
| KEGG | |
PubChem CID
|
|
| UNII | |
| |
| |
| Properties | |
| C7H6O3 | |
| Molar mass | 138.12 g·mol−1 |
| Template:Chembox header2 | Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
{{#subobject:
|Label Page=Salicylic acid |Label Name=Saly 1.jpg
}}
{{#subobject:
|Label Page=Salicylic acid |Label Name=
}}
- ↑ 1.0 1.1 1.2 Template:RubberBible92nd
- ↑ 2.0 2.1 2.2 Template:PubChemLink
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 http://chemister.ru/Database/properties-en.php?dbid=1&id=1777
- ↑ 4.0 4.1 4.2 Seidell, Atherton; Linke, William F. (1952). [Google Books Solubilities of Inorganic and Organic Compounds] Check
|url=value (help). Van Nostrand. Retrieved 2014-05-29. - ↑ Salicyclic acid. Drugbank.ca. Retrieved on 2012-06-03.